Skip to main content
. 2018 Aug 24;97(34):e11860. doi: 10.1097/MD.0000000000011860

Figure 5.

Figure 5

RR of high-grade HTEs in patients associated with HMAs versus CCR. (A) Forest plot of RR of high-grade anemia. (B) Forest plot of RR of high-grade leukopenia. (C) Forest plot of RR of high-grade febrile neutropenia. CCR = conventional care regimens, HMAs = hypomethylating agents, HTEs = hematologic toxicity effects, RR = relative risks.